Houdin Dehnad, Ph.D.
Focus on implant material design in embolic coils, stents and polymer materials
Bohdan Chopko, MD, PhD
There is a significant clinical need to prevent bacteria from contaminating patients upon medical device implantation.
Silver Bullet Therapeutics has developed OrthoFuzIon™ with a regulatory-cleared silver ionization coating for an antimicrobial device implant.
The CMS “Bundled Payments for Care Improvement” (BPCI) may be a dramatic driving force for market adoption of OrthoFuzIon™ and Galvanis™ technology.
Six years of development, testing and animal trials have enabled us to perfect our technology.
Paul Chirico, President & CEO
Why Silver Bullet?
About Silver Bullet
Silver Bullet is developing OrthoFuzIon™, an antimicrobial coating based on proprietary silver ionization technology designed to prevent contaminations associated with medical device implants.